Biogen Inc. buy Wells Fargo & Company
Start price
09.11.23
/
50%
€210.20
Target price
09.11.24
€340.62
Performance (%)
-7.09%
Price
26.04.24
€195.30
Summary
This prediction is currently active. With a performance of -7.09%, the BUY prediction by Wells_Fargo___Compan is trending in the wrong direction. This prediction currently runs until 09.11.24. The prediction end date can be changed by Wells_Fargo___Compan at any time. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Biogen Inc. | 7.014% | 7.014% |
| iShares Core DAX® | 2.594% | -1.861% |
| iShares Nasdaq 100 | 3.553% | -2.064% |
| iShares Nikkei 225® | 0.687% | -8.704% |
| iShares S&P 500 | 2.209% | -1.988% |
Comments by Wells_Fargo___Compan for this prediction
In the thread Biogen Inc. diskutieren
Biogen Inc. (NASDAQ: BIIB) had its price target raised by analysts at Wells Fargo & Company from $343.00 to $365.00. They now have an "overweight" rating on the stock.
Ratings data for BIIB provided by MarketBeat